Cancer Treatment: Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug-Conjugated Stealth Mesenchymal Stem Cells (Adv. Sci. 5/2018)

Isolation of mesenchymal stem cells from fetal tissues

Backgrond&Objective: The ability of mesenchymalstem cells (MSCs) differentiation into many cell types, as well as their ex vivo expansion potential, makes them as an attractive therapeutic tool for cell transplantation and tissue engineering. This project was designed to improve isolation culture and characterization of human amniotic membran-derivedMSSCS and human warton ,s jelly- derived MSCs...

P 141: Mesenchymal Stem Cells as Treatment in Neuroinflammatory Disease

Mesenchymal stem cells can be obtained from deferent tissues like adipose tissue, umbilical cord, placenta, skin, bone marrow, etc. These cells have regulatory effects on all types of immune cells such as dendritic cell, natural killers and lymphocytes. Mesenchymal stem cells induce inhibitory phenotypes of Antigen Presenting Cells (APCs) following their activity. They also change T cells pheno...

An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue

Objective(s): Colon cancer is risen up with its complex mechanism that directly impacts on its treatment as well as its common prevalence. Mesenchymal stem cells (MSCs) have been considered as a therapeutic candidate for conventional disease including cancer. In this research, we have focused on apoptotic effects of adipose tissue-derived MSCs in colon cancer.Materials and Methods: MSCs were ob...

Turning Stem Cells into Mesenchymal Tissues

June 2005 | Volume 2 | Issue 6 | e195 | e198 As mothers get older and assisted conception becomes more common in developed countries, the incidence of multiple births—primarily of nonidentical siblings, but also of identical ones—has dramatically increased. Multiple pregnancies are high-risk pregnancies, with preterm delivery and monochorionicity (shared placenta) the major problems. Consequent...

Cancer Treatment: Enhanced Photodynamic Cancer Treatment by Mitochondria‐Targeting and Brominated Near‐Infrared Fluorophores (Adv. Sci. 3/2018)